AVXL Stock Price History and Quote Analysis Insights for Investors
Anavex Life Sciences Corp.
Stock Price Today
Anavex Life Sciences Corp. (AVXL) stock surged +1.93%, trading at $8.46 on NASDAQ, up from the previous close of $8.30. The stock opened at $8.60, fluctuating between $8.20 and $8.80 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patients with Rett syndrome; Phase II clinical trial for the treatment of Parkinson's disease; and preclinical clinical trials to treat epilepsy, infantile spasms, Fragile X syndrome, Angelman syndrome, multiple sclerosis, and tuberous sclerosis complex. The company's drug candidate also comprises ANAVEX 3-71, which is in Phase I clinical trial for the treatment of frontotemporal dementia and other dementia indications; and preclinical clinical trials for the treatment of neurodegenerative diseases, such as Alzheimer's and Parkinson's diseases. Its preclinical drug candidates include ANAVEX 1-41, a sigma-1 receptor agonist for the treatment of depression, stroke, Parkinson's, and Alzheimer's diseases; ANAVEX 1066, a mixed sigma-1/sigma-2 ligand for the potential treatment of neuropathic and visceral pain; and ANAVEX 1037 to treat prostate and pancreatic cancer. The company was incorporated in 2004 and is headquartered in New York, New York.
Company Information
| Employees | 40 |
| Beta | 0.6 |
| Sales or Revenue | $0.00 |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | September |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Anavex Life Sciences Corp. (NASDAQ: AVXL) stock price is $8.46 in the last trading session. During the trading session, AVXL stock reached the peak price of $8.80 while $8.20 was the lowest point it dropped to. The percentage change in AVXL stock occurred in the recent session was 1.93% while the dollar amount for the price change in AVXL stock was $0.16.
The NASDAQ listed AVXL is part of Biotechnology industry that operates in the broader Healthcare sector. Anavex Life Sciences Corp. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Dr. Edward R Hammond M.D., M.P.H., Ph.D.
Chief Medical Officer
Dr. Emmanuel O. Fadiran RPh, Ph.D.
Senior Vice President of Regulatory Affairs
Ms. Sandra Boenisch CPA, CPA, CGA
Principal Financial Officer & Treasurer
Dr. Walter E. Kaufmann M.D.
Chief Scientific Officer
Clint Tomlinson
Vice President of Corporation
Mr. Stephan Toutain
Chief Operating Officer
Dr. Adebayo Laniyonu Ph.D.
Senior Vice President of Nonclinical Devel.
Dr. Christopher U. Missling M.B.A., M.S., Ph.D.
Chairman, Pres, Chief Executive Officer & Sec.
Dr. Kun Jin Ph.D.
Head of Biostatistics
AVXL's closing price is 160.31% higher than its 52-week low of $3.25 where as its distance from 52-week high of $10.45 is -19.04%.
Number of AVXL employees currently stands at 40.
Official Website of AVXL is: https://www.anavex.com
AVXL could be contacted at phone 844 689 3939 and can also be accessed through its website. AVXL operates from 51 West 52nd Street, New York, NY 10019, United States.
AVXL stock volume for the day was 1.15M shares. The average number of AVXL shares traded daily for last 3 months was 1.15M.
The market value of AVXL currently stands at $717.37M with its latest stock price at $8.46 and 84.8M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com